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Bovine tuberculosis in the United States has proven costly to cattle producers as well as to government
regulatory agencies. While in vivo responsiveness to mycobacterial antigens is the current standard for the
diagnosis of tuberculosis, in vitro assays are gaining acceptance, especially as ancillary or complementary tests.
To evaluate in vitro indices of cellular sensitization, antigen-induced gamma interferon (IFN-), nitric oxide
(NO), and tumor necrosis factor alpha (TNF-) responses by blood mononuclear cells from Mycobacterium
bovis-infected cattle were quantified and compared. Using an aerosol model of infection, two doses of each of
two strains of M. bovis (95-1315 and HC-2045T) were used to induce a range of IFN-, NO, and TNF-
responses. Infection-specific increases in NO, but not in IFN- or TNF-, were detected in nonstimulated
cultures at 48 h, a finding that is indicative of nonspecific activation and spontaneous release of NO. The
infective dose of M. bovis organisms also influenced responses. At 34 days postinfection, IFN-, NO, and TNF-
responses in antigen-stimulated cells from cattle receiving 105 CFU of M. bovis organisms were greater than
responses of cells from cattle infected with 103 CFU of M. bovis organisms. The NO response, but not the IFN-
and TNF- responses, was influenced by infective strains of M. bovis. The TNF-, NO, and IFN- responses
followed similar kinetics, with strong positive associations among the three readouts. Overall, these findings
indicate that NO and TNF-, like IFN-, may prove useful as indices for the diagnosis of bovine tuberculosis.
First described by Robert Koch in 1891, the tuberculin skin
reaction has been the principal means of tuberculosis diagnosis
for both humans and domestic animals (23). For cattle, the
caudal fold skin test (CFT) is the primary approved test for
tuberculosis within the United States. The CFT relies on in
vivo reactivity to Mycobacterium bovis purified protein deriva-
tive (PPDb) injected intradermally into a fold of skin at the
base of the tail. Cattle classified as reactors or suspect with this
test are often retested by using the comparative cervical skin
test, in which PPDb is injected at one site and M. avium PPD
(PPDa) is injected at a separate site. The comparative cervical
skin test, while technically more challenging than the CFT,
provides an added ability to distinguish M. avium (including M.
avium subsp. paratuberculosis) responders from M. bovis re-
sponders. An in vitro method of tuberculosis diagnosis has also
been developed (41) and approved for use in the United States
as a complementary test (i.e., in conjunction with the skin test)
(22). The in vitro assay detects gamma interferon (IFN-)
produced differentially by peripheral blood mononuclear cells
(PBMC) exposed to no antigen (i.e., background response),
PPDa, PPDb, or mitogen (e.g., pokeweed mitogen, PWM)
(40). The assay is particularly suitable for diagnostic laborato-
ries, as whole blood cultures are used, thus circumventing the
need for cumbersome cell separation techniques. More re-
cently, recombinant antigens specific for virulent tubercle ba-
cilli (e.g., ESAT-6, CFP-10, MPB-59, MPB-64, and MPB-70)
have been evaluated for use in tests that discriminate among
M. avium-exposed, M. bovis BCG-vaccinated, and tuberculous
cattle (3, 4, 35). These antigens have demonstrated utility for
both in vitro (i.e., IFN- test) and in vivo (i.e., skin test) use
(12, 20, 27, 28, 34, 39). Despite these advances, there is still a
need for convenient and inexpensive tests for bovine tubercu-
losis.
The proven, practical application of an IFN--based assay
for tuberculosis diagnosis is not surprising considering the ro-
bust cell-mediated response generated by tuberculosis complex
mycobacteria. Indeed, IFN- is crucial for effective host de-
fense during tuberculosis (8, 15, 18, 25, 30). Other readouts of
mycobacterial immunity, especially cellular reactivity, may also
have diagnostic application. Two essential components of tu-
bercular host defense include nitric oxide (NO) and tumor
necrosis factor alpha (TNF-) (1, 13, 14, 16, 17, 21). Stimula-
tion of inducible nitric oxide synthase in macrophages and
subsequent generation of reactive nitrogen intermediates are
potent mechanisms for mycobacterial killing (6, 7, 9, 13, 21).
Mycobacterium-induced TNF- and IFN- secretion by T cells
and/or macrophages from infected individuals is responsible
for an antimycobacterial defense mediated by reactive nitrogen
intermediates (17, 33). TNF- is also necessary for contain-
ment of the infection (i.e., granuloma formation). Mice defi-
cient in TNF- or TNF- receptor are highly susceptible to
fatal mycobacterial infections and fail to develop organized
granulomas (11, 17, 19). NO and TNF-, like IFN-, are
readily produced by mycobacterium-induced PBMC from M.
* Corresponding author. Mailing address: Bacterial Diseases of
Livestock Research Unit, National Animal Disease Center, 2300 Day-
ton Ave., P.O. Box 70, Ames, IA 50010-0070. Phone: (515) 663-7756.
Fax: (515) 663-7458. E-mail: rwaters@nadc.ars.usda.gov.
960
 at UNIV O
F NEBRASKA-LINCO
LN on O







bovis-infected cattle (24, 38), thus demonstrating their poten-
tial as diagnostic readouts for M. bovis infection.
The objective of the present study was to quantify and com-
pare mycobacterium-specific IFN-, NO, and TNF- produc-
tion by PBMC from M. bovis-infected cattle. An aerosol model
of M. bovis infection using two dosages of each of two strains
of M. bovis was used to initiate variable responses for compar-
isons. Isolated PBMC were used for recall stimulation studies
because this population produces vigorous IFN-, NO, and
TNF- responses when stimulated with mycobacterial anti-
gens. Responses were evaluated for effects of challenge dose
and strain, kinetics, and associations.
Twenty crossbred cattle of approximately 9 months of age
and obtained from herds with no history of tuberculosis were
housed at the National Animal Disease Center, United States
Department of Agriculture, Animal Research Service, Ames,
Iowa, according to the Association for Assessment and Ac-
creditation of Laboratory Animal Care International and in-
stitutional guidelines. At the initiation of the study, all animals
were tested and confirmed negative for M. bovis and M. avium
exposure by using a commercially available assay (Bovigam;
CSL Limited, Parkville, Victoria, Australia) for detection of
IFN- responses to in vitro mycobacterial antigen stimulation.
The animals were housed in temperature- and humidity-con-
trolled rooms (1 to 2 animals per room) within a biosafety level
3 confinement facility. Negative airflow exited the building
through HEPA (high efficiency particulate air) filters, ensuring
that air from the animal pens was pulled towards a central
corridor and through HEPA filters before exiting the building.
Airflow velocity was 10.4 air changes per h.
The strains of M. bovis used for the challenge inoculum were
strain 95-1315 (United States Department of Agriculture An-
imal Plant and Health Inspection Service designation), origi-
nally isolated from a white-tailed deer in Michigan (31), and
strain HC-2045T, originally isolated from a Holstein cow in
Texas. Inoculum consisted of mid-log-phase M. bovis cells
grown in Middlebrook’s 7H9 medium supplemented with 10%
oleic acid-albumin-dextrose complex (Difco, Detroit, Mich.)
plus 0.05% Tween 80 (Sigma Chemical Co., St. Louis, Mo.) as
previously described (2). The challenge inoculum consisted of
either 105 (n  5 for each of the two strains) or 103 (n 
5 for each of the two strains) CFU in 2 ml of phosphate-
buffered saline (PBS). The cattle were restrained, and the
challenge inoculum was delivered by nebulization into a mask
covering the animals’ nostrils and mouths (26).
Nineteen of the twenty cattle challenged with M. bovis had
typical tuberculous lesions with M. bovis organisms cultured
from affected tissues. Restriction fragment length polymor-
phism patterns of M. bovis organisms isolated from tissues
matched the challenge inoculum strain. Tracheobronchial and
mediastinal lymph nodes and lungs were the most commonly
affected tissues. Lung lesions were distributed diffusely among
all lobes, consistent with aerosol exposure to droplet nuclei of
5 m. Lesions were more severe and disseminated in cattle
receiving the higher challenge dosage (i.e., 105 CFU), regard-
less of the challenge strain. Although it is difficult to determine
the actual number of tuberculous lesions per animal, lesions
were detected in more sites (i.e., organs, lymph nodes, lung
lobes, etc.) in cattle receiving 105 CFU of strain HC-2045T
than in those receiving 105 CFU of strain 95-1315. The num-
bers of lesion sites did not differ between challenge strains for
cattle receiving 103 CFU. Detailed descriptions of gross, his-
tologic, and bacteriologic findings are presented elsewhere
(26).
PBMC were isolated from buffy coat fractions of peripheral
blood collected in 2 acid citrate dextrose (5). The wells of
96-well round-bottom microtiter plates (Falcon; Becton Dick-
inson, Lincoln Park, N. J.) were seeded with 2  105 PBMC in
a total volume of 200 l per well. The medium was RPMI 1640
supplemented with 2 mM L-glutamine, 25 mM HEPES buffer,
100 units of penicillin per ml, 0.1 mg of streptomycin per ml,
1% nonessential amino acids (Sigma), 2% essential amino
acids (Sigma), 1% sodium pyruvate (Sigma), 50 M 2-mercap-
toethanol (Sigma), and 10% (vol/vol) fetal bovine serum. The
wells contained medium plus 5 g per ml, of PPDb (CSL
Limited) 5 g per ml of PPDa (CSL Limited) 10 g per ml, of
M. bovis strain 95-1315 whole-cell sonicate (WCS) 10 g per
ml, of M. bovis strain HC-2045T WCS or 1 g per ml, of PWM
or medium alone (no stimulation) per ml. The WCS antigens
were prepared from 4-week M. bovis cultures grown in Middle-
brook’s 7H9 medium supplemented with 10% oleic acid-albu-
min-dextrose complex. Bacilli were pelleted, sonicated in PBS,
further disrupted with 0.1 to 0.15 mm glass beads (Biospec
Products, Bartlesville, Okla.) in a bead beater (Biospec Prod-
ucts), and then placed on ice. The preparation was centrifuged,
and the supernatant was harvested and filtered (0.22 m).
After incubation of PBMC cultures for 48 h at 37°C in 5%
CO2, the supernatants were harvested and stored at 	80°C
until thawed for analysis.
Nitrite is the stable oxidation product of NO, and the
amount of nitrite within culture supernatants is indicative of
the amount of NO produced by cells in culture. Nitrite was
measured by using the Griess reaction (29) performed in 96-
well microtiter plates (Immunolon 2; Dynatech Laboratories,
Inc., Chantilly, Va.). Nitrite concentrations in the supernatants
were also determined by high-performance ion chromatogra-
phy (HPIC). Briefly, macromolecules were separated from the
aqueous portion of the sample by centrifugation through a
30,000-Da molecular mass cutoff filter. The microfiltrate was
collected and injected directly into an ion-exchange high-pres-
sure liquid chromatography system. A 4.1-by 250-mm strong
anion-exchange column with a 10-m inside diameter was
used. The mobile phase consisted of an aqueous solution con-
taining 5.28 g of NaH2PO4  H2O, 43.46 g of Na2HPO4  7
H2O, 2.40 g of NaCl, and 100 ml of acetonitrile per liter.
Nitrate was detected by absorbance at 214 nm; nitrite was
detected by absorbance at 530 nm after a postanalytical col-
umn diazo-coupling reaction with an aqueous solution contain-
ing 100 ml of 85% o-phosphoric acid, 40.00 g of sulfanilamide,
and 2.00 g of N-(1-naphthyl)ethylenediamine dihydrochloride
per liter. Ions were quantitated against their respective stan-
dard curves.
A commercial enzyme-linked immunosorbent assay (ELISA)-
based kit (Bovigam; CSL Limited) was used for determination
of IFN- concentrations in culture supernatants. Duplicate
samples for each individual treatment were analyzed. Each
treatment represented three pooled replicate samples. TNF-
was measured by using a TNF- capture ELISA (protocol and
reagents were provided by L. Babiuk, Veterinary Infectious
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Diseases Organization, Saskatoon, Saskatchewan, Canada).
The assays were performed in Immunolon II microtiter plates
(Dynatech Laboratories, Inc., Chantilly, Va.). Reagents
consisted of a capture antibody (mouse ascites anti-TNF-,
immunoglobulin G [IgG] fraction), a detection antibody, re-
combinant bovine TNF- (IgG fraction), biotinylated goat an-
ti-rabbit IgG (Zymed Laboratories, Inc., South San Francisco,
Calif.), horseradish peroxidase-conjugated streptavidin-biotin-
ylated complex (Amersham Corporation, Arlington Heights,
Ill.), substrate (H2O2 at 0.1%, vol/vol), and dye (2,2
-azinodi-
ethylbenzothiazoline-sulfonic acid). Internal standards of seri-
ally diluted rabbit anti-bovine TNF- were prepared in PBS
(pH 7.2, 0.01 M) with Tween 80 (0.1%, vol/vol) and gelatin
(0.5%, vol/vol) (PBST-g). The positive and negative controls
and test samples were also diluted serially in PBST-g. Capture
antibody was diluted (1:1,000, vol/vol) in carbonate buffer (pH
9.6, 0.01 M), and detection antibody was diluted in PBST-g
(1:1,500, vol/vol). Biotinylated goat anti-rabbit Ig was diluted
1:10,000, and horseradish peroxidase-conjugated streptavidin-
biotinylated complex was diluted 1:2,000 in PBST without gel-
atin. Intervening washes were done with PBST without gelatin.
Enzyme substrate and indicator were dye diluted in citrate
buffer. All incubations were at room temperature with the
exception of that of capture antibody in carbonate buffer,
which was incubated at 4°C. The absorbance of the standards
and test samples was read at 405 and 490 nm using an ELISA
plate washer and reader (Dynatech MR7000). TNF- concen-
trations (nanograms per milliliter) in the test samples were
determined by comparing the absorbancy of the test samples
with the absorbancy of standards within a linear curve fit.
The data were assessed for normality prior to statistical
analysis. Arithmetic and log10-transformed data were analyzed
as a split plot with repeated-measure analysis of variance
(ANOVA) using Statview software (version 5.0; SAS Institute,
Inc., Cary, N.C.). The statistical model included the effects of
treatment (i.e., challenge strain and challenge dose), time
(days relative to challenge), and the interaction of treatment
and time on nitrite, IFN-, and TNF- concentrations in su-
pernatants from PBMC cultures. Fisher’s protected-least sig-
nificant difference test was applied when significant effects (P
of 0.05) were detected by the model. Pearson’s product-
moment correlations were computed between nitrite produc-
tion measured using Greiss and HPIC assays, as well as be-
tween concentrations of nitrite, IFN-, and TNF- in culture
supernatants.
To validate the Griess reaction assay in our culture system,
supernatants (49 samples) were evaluated for nitrite by HPIC
at an accredited toxicology laboratory (i.e., University of Ne-
braska Veterinary Diagnostic Center) and by the Griess reac-
tion (i.e., at the National Animal Disease Center). Samples
included supernatants from PBMC cultures stimulated with
medium alone, PPDa, PPDb, and PWM. Blood samples were
collected at prechallenge (day 0) and at 34 days, 68 days, and
124 days postchallenge. For the analysis, supernatants repre-
senting a predicted wide range of responses were included. As
demonstrated in Fig. 1, results from the two assays had a strong
positive linear association (r  0.94, P  0.0001; y  0.57x 
70.87), suggesting that both the Griess and HPIC assays gen-
erated similar results. The strongest associations between the
Griess and HPIC assays were observed for samples from stim-
FIG. 1. Comparison of the results of the Griess reaction with those
of HPIC for the measurement of nitrite in 48-h culture supernatants.
The measurements (n  49) utilized in this analysis were from four
time points (prechallenge [day 0] and 34, 68, and 124 days postchal-
lenge) and stimuli (nonstimulated [medium alone] and stimulated with
PPDa, PPDb, or PWM). The symbols () represent individual re-
sponses, and the line was generated by linear regression analysis (r 
0.94, P  0.0001; y  0.57x  70.87).
FIG. 2. Spontaneous production of nitrite by nonstimulated PBMC
during the experimental period. Nitrite production (means  SEMs)
in supernatants from 48-h nonstimulated cultures was measured by the
Griess reaction. Asterisks (***) indicate that results for the postchal-
lenge response differed (P  0.001) from those for the prechallenge
(day 0) response.
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ulated cultures (for PPDa, r  0.92, y  0.45x  87; for PPDb,
r  0.96, y  0.55x  72; for PWM, r  0.90, y  0.48x  95),
which generated a wider range of responses than those from
nonstimulated cultures (for medium alone, r  0.18, y  0.11x
 72.5), in which there was a minimal response.
Nonspecific activation of circulating PBMC may alter spon-
taneous production of IFN-, nitrite, or TNF- in nonstimu-
lated cultures. Indeed, M. bovis BCG infection or intraperito-
neal lipopolysaccharide injection of C3H/HeJ mice induces a
five- to sixfold increase in serum nitrite or nitrate levels, re-
sulting from increased production of NO by macrophages (32).
Levels of IFN- in supernatants from 48-h nonstimulated
PBMC cultures (0.07  0.006 [mean  standard error of the
mean {SEM}] for samples throughout the study) were unaf-
fected (P  0.05) by time relative to infection or by the dosage
or strain of M. bovis challenge (data not shown). Likewise,
TNF- levels in supernatants from nonstimulated cultures
were unaffected (P 0.05) by the dosage or strain of inoculum.
However, less (P  0.01) TNF- was detected in supernatants
from nonstimulated cultures collected at 68 days postchallenge
(0.91 0.05) than in those collected at 0 days (1.82 0.25), 34
days (1.71  0.21), and 124 days (2.15  0.31) postchallenge,
regardless of dosage or the strain of M. bovis. In contrast to
results for IFN- and TNF-, increases in nitrite relative to
prechallenge levels were detected at 34 days, 68 days, and 124
days postchallenge (Fig. 2) (combined data including both dos-
ages and strains; n  20) in 48-h supernatants from nonstimu-
lated cultures. Furthermore, increases (P  0.05) in spontane-
ous nitrite production upon infection were detected for each of
FIG. 3. Effects of challenge dose and time relative to challenge on IFN-, nitrite, and TNF- responses of cells in vitro. Blood mononuclear
cells were isolated from cattle immediately prior to challenge (day 0) and at 34 days, 68 days, and 124 days after challenge with 103 (closed triangles,
n  10) or 105 (open boxes, n  10) CFU of M. bovis strain 95-1315 organisms. The cells were cultured for 48 h with medium alone or with 5 g
of PPDb per ml. IFN- and TNF- concentrations in culture supernatants were quantified by ELISA, and nitrite concentrations were quantified
by the Griess reaction. Values are presented as mean ( SEM) responses to M. bovis PPDb stimulation minus the response to medium alone. An
asterisk (*) indicates that the values for the responses for cattle receiving 105 CFU of PBMC differed (P  0.05) from the values for the responses
for cattle receiving 103 CFU of M. bovis organisms.
TABLE 1. Longitudinal IFN-, nitrite, and TNF- responses of
blood mononuclear cells to stimulation with PPDba
Prechallenge or day
after challenge
Mean responses  SEMb
IFN- (OD) Nitrite (ng/ml) TNF- (ng/ml)
Prechallenge 0  0 A 	10  5 A 	0.34  0.09 A
34 0.84  0.26 B 129  41 C 0.58  0.29 B
68 0.93  0.22 B 101  24 BC 1.28  0.38 C
124 0.55  0.19 B 59  23 B 	0.03  0.16 A
a Blood mononuclear cells were isolated immediately prior to challenge (day
0) and at 34 days, 68 days, and 124 days after challenge and were cultured for 48 h
with medium alone or with 5 g of PPDb per ml. IFN- and TNF- concentra-
tions were quantified by ELISA, and nitrite concentrations were quantified by
the Griess reaction. Data were analyzed by repeated-measure ANOVA with P
values of 0.001, 0.001, and 0.0001 for IFN-, nitrite, and TNF-, respectively.
Values followed by different letters are significantly different (P  0.05).
b Values represent mean responses ( SEM, n  20) to PPDb stimulation
minus responses to medium alone.
TABLE 2. IFN-, nitrite, and TNF- responses of blood
mononuclear cells from cattle infected with M. bovis to soluble
M. bovis antigensa
Stimulant (concn)
Mean responses  SEMb
IFN- (OD) Nitrite (ng/ml) TNF- (ng/ml)
HC-2045T WCS (10 g/ml) 0.84  0.24 A 125  39 A 1.34  0.38 A
95-1315 WCS (10 g/ml) 0.12  0.04 B 45  20 B 0.21  0.09 B
PPDa (5 g/ml) 0.24  0.06 B 41  20 B 0.15  0.11 B
PPDb (5 g/ml) 0.93  0.22 A 101  24 A 1.28  0.38 A
PWM (1 g/ml) 2.91  0.29 137  21 2.60  0.30
a Blood mononuclear cells were isolated from cattle 68 days postchallenge.
IFN- and TNF- concentrations in culture supernatants were quantified by
ELISA, and nitrite concentrations were quantified by the Griess reaction. Values
followed by different letters are significantly different (P  0.05).
b Values represent mean ( SEM, n  20) responses to stimulation (i.e.,
antigen or PWM) minus the response to medium alone. Responses to PWM are
presented to indicate a general responsiveness of the cell population to poly-
clonal stimulation (i.e., a positive control), and these responses were not com-
pared to the responses of antigen-stimulated cells.
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the groups (i.e., split by dose and strain; n 5) when they were
analyzed separately (data not shown). In general, spontaneous
NO production increased upon infection, whereas minimal to
no increases in spontaneous release of IFN- or TNF- were
observed. Similarly, NO within exhaled air (36) and NO pro-
duced spontaneously by PBMC (37) increases in humans in-
fected with M. tuberculosis.
The challenge dosage of M. bovis administered influenced
responses with greater (P  0.01, n  10; 34 days postchal-
lenge) levels of IFN-, nitrite, and TNF- detected in super-
natants from PPDb-stimulated cultures from cattle receiving
105 CFU of M. bovis organisms than in those receiving 103
CFU of M. bovis organisms (Fig. 3). Dosage effects were not
detected at 0 days, 68 days, or 124 days postchallenge. In-
creases (P  0.01, n  20) in IFN-, nitrite, and TNF- levels,
regardless of dose or strain of inoculum, were detected in
supernatants from PPDb-stimulated cultures at 34 days and 68
days postchallenge in comparison to those of prechallenge
responses (Table 1). PPDb-induced IFN- and nitrite levels
were also increased (P  0.05) at 124 days postchallenge in
comparison to those of prechallenge responses (Table 1).
IFN-, nitrite, and TNF- responses to either PPDb or HC-
2045T WCS exceeded (P  0.05) the respective responses to
either PPDa or 95-1315 WCS (Table 2), regardless of the
challenge strain. In general, challenge dosage, duration of in-
fection, and type of antigen used for stimulation affected
IFN-, nitrite, and TNF- responses similarly.
The antigen-specific IFN- and TNF- responses of cattle
infected with strain HC-2045T did not differ (P  0.05, repeat-
ed-measure ANOVA; 0 to 124 days postchallenge; n  10)
from those of cattle infected with strain 95-1315. In contrast,
nitrite responses to PPDb, PPDa, HC-2045T WCS, and 95-
1315 WCS of PBMC from HC-2045T-infected cattle exceeded
(P 0.05) those of 95-1315-infected cattle (Fig. 4). While clear
differences in disease severity among animals receiving equiv-
alent doses of the two strains were difficult to determine, it did
appear that cattle receiving the HC-2045T strain had slightly
more severe cases of the disease than did cattle receiving the
95-1315 strain. Lesions were detected at more sites in cattle
receiving 105 CFU of HC-2045T than in cattle receiving 105
CFU of 95-1315, likely impacting the nitrite response.
Both IFN- and TNF- are known to induce NO production
(10, 17). Associations among these three responses by cattle
PBMC to M. bovis antigens, however, are not clear. To evalu-
ate these associations, differential responses to mycobacterial
antigens of all M. bovis-infected cattle (n  20) at 0 days, 34
days, 68 days, and 124 days postchallenge were evaluated by
linear regression analysis (Table 3). In general, strong positive
associations between all three readouts (i.e., IFN-, nitrite, and
TNF-) were detected with antigen-specific responses. Poor to
no associations were detected with these responses to no stim-
ulation or to PWM.
FIG. 4. Effects of challenge strain on nitrite responses. Blood mononuclear cells collected immediately before challenge (day 0) and at 0 days,
34 days, 68 days, or 124 days after being challenged with M. bovis strain 95-1315 (closed triangles, n 10) or M. bovis strain HC-2045T (open boxes,
n  10) were cultured with 5 g of PPDb per ml, 5 g of PPDa per ml, 10 g of M. bovis strain 95-1315 WCS per ml, or 10 g of M. bovis strain
HC-2045T WCS per ml. Nitrate concentrations in 48-h culture supernatants were quantified by the Griess reaction. The P values for the effects
of the strains are indicated on each graph.
TABLE 3. Association between IFN-, nitrite, and TNF-
responses by blood mononuclear cells from M. bovis-infected cattle
to antigens and mitogena
Stimulant (concn)
Correlation coefficient (r)b
IFN- vs nitrite IFN- vs TNF- Nitrite vs TNF-
Medium alone (no stimulant) 0.36** NS NS
HC-2045T WCS (10 g/ml) 0.54**** 0.61**** 0.47****
95-1315 WCS (10 g/ml) 0.67**** 0.35** 0.24*
PPDb (5 g/ml) 0.69**** 0.73**** 0.54****
PPDa (5 g/ml) 0.46**** 0.41**** 0.34**
PWM (1 g/ml) 0.37*** NS 0.24*
a Blood mononuclear cells were isolated from cattle immediately prior to
challenge (day 0) and at 34 days, 68 days, and 124 days after challenge and
cultured for 48 h in medium alone or medium plus antigen or mitogen. Super-
natant IFN- and TNF- concentrations were quantified by ELISA, and nitrite
concentrations were quantified by the Griess reaction. NS, not significant.
b Asterisks indicate significant correlatoins at a P of  0.05 (*),  0.01 (**), 
0.001 (***), or  0.0001 (****).
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In vitro-based cellular immune assays are gaining wide ac-
ceptance for use in tuberculosis diagnosis. Of relevance to
cattle, an IFN- assay (in conjunction with skin testing) was
recently approved for use in tuberculosis diagnosis. Other
readouts of bovine cellular immune responsiveness (e.g.,
TNF- and NO), however, have not been critically analyzed or
compared to the IFN- response. In the present study, TNF-
and NO responses upon M. bovis infection followed similar
kinetics, as did IFN- responses (Fig. 3 and 4; Table 1). The
relative magnitude of each of these responses to variable an-
tigens was consistent (Tables 1 and 2), and recall IFN-,
TNF-, and NO responses to crude M. bovis soluble antigens
were clearly associated (Table 3). Thus, evaluation of TNF-
and NO responses, like that of IFN- responses, may prove
useful for diagnosis of bovine tuberculosis. The nonspecific
production of nitrite in PBMC cultures from infected cattle
(Fig. 2) may be problematic for development of a useful NO-
based diagnostic assay of infection. However, the NO response
to M. bovis antigens generally exceeded the response to me-
dium alone, thereby providing antigen specificity (Tables 1 and
2). As with the IFN- assay, adaptation of NO and TNF-
assays to a whole-blood format and usage of recombinant anti-
gens will be necessary to enhance the practicality and specific-
ity of these assays.
We thank Theresa Rahner, Rebecca Lyon, Jody Mentele, and Ryan
Cook for technical assistance and Nate Horman, Larry Wright, Doug
Ewing, Don Robinson, Norm Lyon, and Wayne Varland for animal
care.
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